Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages 21-27

  Srinivasan, Ramya ^a   Song, Yuanlin ^a   Wiener Kronish, Jeanine ^b   Flori, Heidi R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

biological markers; intensive care unit; pediatric; plasminogen activation inhibitor; receptor for advanced glycation end products; soluble triggering receptor expressed on myeloid cells; surfactant protein D; ventilator associated pneumonia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SURFACTANT PROTEIN D;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BONE MARROW CELL; CHILD; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENDOTRACHEAL INTUBATION; FEMALE; GRAM STAINING; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; INTUBATION; LOWER RESPIRATORY TRACT INFECTION; LUNG INJURY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SCHOOL CHILD; SCREENING; TERTIARY HEALTH CARE; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 78751646073     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e2a352     Document Type: Article

References (38)

1. National Nosocomial Infectons Surveilllance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485
2. Chastre J, Fagon J-Y: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
3. Elward AM, Warren DK, Fraser VJ: Ventilator-associated pneumonia in pediatric intensive care patients: Risk factors and outcomes. Pediatrics 2002; 109:758-764
4. Srinivasan R, Asselin J, Gildengorin G, et al: A prospective study of ventilator-associated pneumonia in children. Pediatrics 2009; 123: 1108-1115
5. Porzecanski I, Bowton DL: Diagnosis and treatment of ventilator- associated pneumonia. Chest 2006; 130:597-604
6. Fàbregas N, Ewig S, Torres A, et al: Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873
7. Leteurtre S, Martinot A, Duhamel A, et al: Validation of the paediatric logistic organ dysfunction (PELOD) score; prospective, observational, multicenter study. Lancet 2003; 362:192-197
8. Erratum in: Lancet 2006; 367: 897
9. Pollack MM, Patel KM, Ruttimann UE: PRISM III: An updated Pediatric Risk of Mortality score. Crit Care Med 1996; 24:743-752
10. Horan TC, Andrus M, Dudeck MA: CDC/ NHSN surveillance definitions of health-care associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332.
11. Erratum in: Am J Infect Control 2008; 36:655
12. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308
13. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
14. Bernard G, Artigas A, Brigham K, et al: The North American-European consensus conference on ARDS. Am J Respir Crit Care Med 1994; 149:818-824
15. Goldstein B, Giroir B, Randolph A, et al: International Pediatric Sepsis Consensus Conference: Definitions of sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8
16. Heyland DK, Cook DJ, Griffith L, et al: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999; 159:1249-1256
17. Rello J, Diaz E, Roque M, et al: Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 1999; 159:1742-1746
18. Gibot S, Cravoisy A, Levy B, et al: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004; 350:451-458
19. Pugin J, Auckenthaler R, Mili N, et al: Diagnosis of ventilator- associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic ''blind'' bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1121-1129
20. Song Y, Lynch SV, Flanagan J, et al: Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa. Anesthesiology 2007; 106: 252-261
21. Renckens R, Roelofs JJ, Bonta PI, et al: Plas-minogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 2007; 109:1593-1610
22. van Zoelen MA, Schouten M, de Vos AF, et al: The receptor for advanced glycation end products impairs host defense in pneumo-coccal pneumonia. J Immunol 2009; 182: 4349-4356
23. Jounblat R, Clark H, Eggleton P, et al: The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia. Respir Res 2005; 6:126
24. Gunther A, Mosavi P, Heinemann S, et al: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161: 454-462
25. Schultz MJ, Millo J, Levi M, et al: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 2004; 59: 130-135
26. De Blic J, Midulla F, Barbato A, et al: ERS Task Force on bronchoalveolar lavage in children. Eur Respir J 2000; 15:217-231
27. El-Sohl AA, Okada M, Pietrantoni C, et al: Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: Impact of inadequate antimicrobial therapy. Intensive Care Med 2004; 10:1914-1920
28. Oudhis GJ, Beuving J, Bergmans D, et al: Soluble triggering receptor expressed on my-eloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 2009; 7:1265-1270
29. Determann RM, Millo JL, Gibot S, et al: Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005; 31: 1495-1500
30. Horonenko G, Hoyt JC, Robbins RA, et al: Soluble triggering receptor expressed on my-eloid cell-1 is increased in patients with ventilator-associated pneumonia: A preliminary report. Chest 2007; 132:58-63
31. Huh JW, Lim CM, Koh Y, et al: Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveo-lar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008; 12:R6
32. Anand NJ, Zuick S, Klesney-Tait J, et al: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009; 135:641-647
33. Zhang J, Tasaka S, Shiraishi, et al: Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008; 178: 356-362
34. Herold K, Moser B, Chen Y, et al: Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 2007; 2:204-212
35. Uchida T, Shirasawa M, Ware L, et al: Receptor for advanced glycation end products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173:1008-1015
36. Crouch E, Wright JR: Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001; 63:521-554
37. LeVine AM, Whitsett JA, Gwozdz JA, et al: Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165:3934-3940
38. Noah TL, Murphy PC, Alink JJ, et al: Bron-choalveloar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 685-691